Error loading player: No playable sources found
2065
Cirrhosis and Portal Hypertension
Date
May 3, 2025
This product is not available for individual purchase, but it is available as part of the following products:
Don't miss the opportunity to access the latest research and discoveries in the field of digestive diseases. DDW On Demand is a valuable and convenient way to enhance your knowledge and skills in digestive disease care…
Society: AGA/AASLD
This session on Cirrhosis and Portal Hypertension will explore various non-invasive models for predicting varices in patients with cirrhosis. Attendees will gain insights from multiple presentations, including studies on secondary SBP prophylaxis, venous excess ultrasound-guided albumin administration, and plasma proteomic profiles for predicting liver cirrhosis-related events. Additionally, the session will cover the validation of care pathways for MASLD and the impact of SGLT-2 inhibitors on portal hypertension complications and mortality
This session on Cirrhosis and Portal Hypertension will explore various non-invasive models for predicting varices in patients with cirrhosis. Attendees will gain insights from multiple presentations, including studies on secondary SBP prophylaxis, venous excess ultrasound-guided albumin administration, and plasma proteomic profiles for predicting liver cirrhosis-related events. Additionally, the session will cover the validation of care pathways for MASLD and the impact of SGLT-2 inhibitors on portal hypertension complications and mortality
Moderators
University of Virginia
Virginia Commonwealth University Health System
Related Products
Annual Business Meeting
SOCIETY: SSAT
Academic Debate: Advanced ALD and Alcohol-Associated Hepatitis Finding the Best Path for Your Patient
This session includes audience response. Visit gastro.cnf.io during the scheduled session time to participate. This session will be a debate regarding the PROS and CONS of steroids and clinical trials for the treatment of alcohol-associated hepatitis…
